H16R8

General Information


DRACP ID  DRACP05397

Peptide Name   H16R8

Sequence  HHHHHHHHHHHHHHHHRRRRRRRRRRRRRRR

Sequence Length  31

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C186H294N108O32

Absent amino acids  ACDEFGIKLMNPQSTVWY

Common amino acids  H

Mass  509034

Pl  13.65

Basic residues  31

Acidic residues  0

Hydrophobic residues  0

Net charge  31

Boman Index  -29836

Hydrophobicity  -382.9

Aliphatic Index  0

Half Life 
  Mammalian: 3.5 hour
  Yeast: 10 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25193363

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2138

DRACP is developed by Dr.Zheng's team.